DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) share price today?

INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) is trading at ₹370.8 on the NSE, down 0.92% on the day. Source: DocStoX.

What is the PE ratio of INDRAPRASTHA MEDICAL CORP?

INDRAPRASTHA MEDICAL CORP has a price-to-earnings (PE) ratio of 21.1 in the Healthcare Services sector.

What is the market capitalisation of INDRAPRASTHA MEDICAL CORP?

INDRAPRASTHA MEDICAL CORP has a market capitalisation of approximately ₹3,406 crore.

INDRAPRASTHA MEDICAL CORP

INDRAMEDCO·NSE·Healthcare Services

₹370.80▼ -3.45 (-0.92%)

Healthcare Services · Hospitals

Debt-free and consistently profitable

Day₹366.00

₹376.30

52W₹342

₹64110%

Open

₹374.60

High

₹376.30

Low

₹366.00

Prev Close

₹374.25

Volume

1.04L

VWAP

₹369.65

Snapshot

Key fundamentals

Market Cap

₹3,406 Cr

P/E Ratio

21.12Fair

P/B Ratio

4.70

EPS

₹17.56

Book Value

₹80.76

ROE

26.98%Strong

ROCE

39.00%Efficient

Dividend Yield

1.19%

Debt / Equity

0.05Low

Face Value

₹10.00

52W High

₹640.85

52W Low

₹342.00

Sector

Healthcare Services

Industry

Hospitals

Avoid

Narrow moatMedium uncertainty

Fair value estimate

₹155

▼ 58.3%downside

Trading at ₹371 — 58% above our estimate

BearFair valueBull

₹132₹155₹179

/100

Business quality — Solid

Growth 0Profitability 77Efficiency 58Valuation 85

Plain English

Our view

Debt-free and consistently profitable
Virtually debt-free balance sheet

Strengths

Virtually debt-free balance sheet
Strong returns on equity (27%)
Capital is working hard (ROCE 39%)
Promoters hold a controlling stake

How we got there

Fair value methods

Residual income

27% ROE fading to 12% over ~10 yrs, on ₹81 book

₹148

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹179

Analyst target

No analyst coverage

—

Blended fair value₹155

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet
Strong returns on equity (27%)
Capital is working hard (ROCE 39%)
Promoters hold a controlling stake

Bear case

No notable red flags from the current metrics.

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

21.1Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

27.0%Strong

Above 15% is considered healthy for Indian equities

ROCE

39.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.05Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹3,406 Cr

P/B

4.70

EPS

₹17.56

Div Yield

1.19%

What changed

Recent changes

Foreign investors+0.3% stake last quarter
Domestic institutions-0.3% stake last quarter

What matters

News impact

Overview

Valuation

Reasonable

P/E 21.1×

Growth

Steady

+10% rev CAGR

Profitability

Excellent

27.0% ROE

Financial health

Rock solid

D/E 0.05

Momentum

N/A

No technicals

Today

Trading activity

Delivery %54.3%

Turnover₹385.08L Cr

Trades3,286

VWAP₹369.65

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+10.5%

+19.3%

10Y

+7.0%

Profit

+28.8%

+146.9%

10Y

+22.6%

EPS

—

10Y

—

Profile

Pros

Company is almost debt free.
Company has delivered good profit growth of 132% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%
Company has been maintaining a healthy dividend payout of 26.3%

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Foreign investors bought 0.34 pts; domestic institutions reduced 0.28 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

51%

Promoter

Promoters

51.0%0.00

Public

45.6%-0.04

FII / FPI

2.8%+0.34

DII

0.6%-0.28

Quarterly trend

Ownership over time

Q1 FY27

Promoter51.00%

FII2.77%

DII0.59%

Public45.65%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions